Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

PFE

Pfizer Inc.

Jun 25 • 04:00PM ET

27.99

Dollar change -0.37
Percentage change -1.30	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO SCHD SPY IVV VTV XLV VYM VHT IWD

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-0.06	Insider Own	0.04%	Shs Outstand	5.67B	Perf Week	3.74%
Market Cap	158.61B	Forward P/E	10.25	EPS next Y	2.73	Insider Trans	0.00%	Shs Float	5.66B	Perf Month	-2.44%
Income	-288.00M	PEG	-	EPS next Q	0.46	Inst Own	68.71%	Short Float	1.34%	Perf Quarter	2.04%
Sales	55.09B	P/S	2.88	EPS this Y	27.62%	Inst Trans	0.52%	Short Ratio	1.98	Perf Half Y	-1.13%
Book/sh	16.28	P/B	1.72	EPS next Y	16.24%	ROA	-0.14%	Short Interest	75.97M	Perf Year	-26.92%
Cash/sh	2.10	P/C	13.30	EPS next 5Y	14.03%	ROE	-0.30%	52W Range	25.20 - 37.80	Perf YTD	-2.78%
Dividend Est.	1.69 (6.04%)	P/FCF	31.06	EPS past 5Y	-27.43%	ROI	-0.19%	52W High	-25.95%	Beta	0.67
Dividend TTM	1.66 (5.93%)	Quick Ratio	0.78	Sales past 5Y	10.96%	Gross Margin	48.87%	52W Low	11.07%	ATR (14)	0.61
Dividend Ex-Date	May 09, 2024	Current Ratio	1.05	EPS Y/Y TTM	-101.00%	Oper. Margin	3.23%	RSI (14)	49.62	Volatility	2.07% 2.11%
Employees	88000	Debt/Eq	0.75	Sales Y/Y TTM	-40.73%	Profit Margin	-0.52%	Recom	2.31	Target Price	32.57
Option/Short	Yes / Yes	LT Debt/Eq	0.66	EPS Q/Q	-43.40%	Payout	439.41%	Rel Volume	0.64	Prev Close	28.36
Sales Surprise	7.25%	EPS Surprise	58.98%	Sales Q/Q	-18.61%	Earnings	May 01 BMO	Avg Volume	38.39M	Price	27.99
SMA20	-0.88%	SMA50	1.31%	SMA200	-3.30%	Trades		Volume	26,300,712	Change	-1.30%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60
Nov-18-22	Initiated	Credit Suisse	Outperform	$55
May-23-22	Initiated	SVB Leerink	Mkt Perform	$55
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$55
Jan-05-22	Upgrade	BofA Securities	Neutral → Buy	$59 → $70
Jan-03-22	Reiterated	Bernstein	Mkt Perform	$44 → $65

Show Previous Ratings

Today 03:12AM	Pharma M&A: The top high value deals in 2023 (Pharmaceutical Technology)
Jun-25-24 05:45PM	Pfizer (PFE) Stock Sinks As Market Gains: Here's Why (Zacks)
09:45AM	Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk? (Motley Fool)
06:28AM	5 Dividend Stocks Yielding at Least 5% to Buy Right Now for Passive Income (Motley Fool)
05:04AM	Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks (Motley Fool)
04:30PM	Loading…
Jun-24-24 04:30PM	3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains (InvestorPlace)
01:02PM	Britain snubs GSK in favour of US pharma giant for RSV vaccine (The Telegraph)
10:33AM	Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success (InvestorPlace)
10:06AM	Alnylam Soars After Drug Meets Goal in Heart Disease Trial (Bloomberg)
09:51AM	Did Seagen Acquisition Help Pfizer Inc. (PFE) Increase Revenue in Q1? (Insider Monkey)
09:13AM	10 Best Healthcare Stocks to Buy According to Hedge Funds (Insider Monkey)
07:15AM	2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market (Motley Fool)
04:20AM	Alnylam says heart drug succeeds in closely watched study (BioPharma Dive)
04:20AM	Alnylam claims success in closely watched heart drug study (BioPharma Dive)
Jun-23-24 01:38PM	7 Dividend Stocks to Buy Now: June 2024 (InvestorPlace)
05:42AM	Loading…
05:42AM	Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks (Motley Fool)
Jun-22-24 07:27AM	The Most Populated Country in the World (Insider Monkey)
07:20AM	50 Most Populated Countries in the World (Insider Monkey)
07:15AM	3 No-Brainer Stocks to Buy for Under $100 Right Now (Motley Fool)
06:03AM	3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold (Motley Fool)
Jun-21-24 04:28PM	Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy (Investor's Business Daily)
01:02PM	Sareptas Elevidys secures US label expansion for DMD (Pharmaceutical Technology)
10:42AM	Sarepta Stock Surges on Expanded Elevidys Approval. Its a Best-Case Scenario for Shares. (Barrons.com)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:40AM	Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy (Investor's Business Daily)
Jun-20-24 07:42PM	Palantir and Pfizer CEOs meet U.S. Senators to press for Israel support and hostage release (CNBC TV)
04:16PM	Why Wall Street Is Chasing Ozempic Wannabes (The Wall Street Journal)
01:26PM	Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates Is It A Sell? (Investor's Business Daily)
01:22PM	Sarepta Duchenne gene therapy wins broader use from FDA (BioPharma Dive)
12:43PM	Skip Meme Mania: 3 Undervalued Blue-Chip Stocks for Steady Returns (InvestorPlace)
12:39PM	Loading…
12:39PM	Pfizer (CNBC TV)
08:00AM	3 Underrated Dividend Stock Machines to Turbocharge Your Income (InvestorPlace)
07:30AM	7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027 (InvestorPlace)
Jun-19-24 01:09PM	From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data (PR Newswire)
Jun-18-24 05:45PM	Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider (Zacks)
01:31PM	Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval (Barrons.com)
01:02PM	MSD competes with Pfizer in pneumococcal vaccine market after FDA approval (Pharmaceutical Technology)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts (Business Wire)
10:00AM	Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb (Motley Fool)
08:06AM	Merck wins FDA OK for vaccine rival to Pfizers pneumococcal shot (BioPharma Dive)
Jun-17-24 02:51PM	Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit (Reuters)
09:54AM	Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best (Insider Monkey)
04:32AM	Pfizer reports data from Phase II multiple myeloma treatment trial (Clinical Trials Arena)
Jun-15-24 05:57PM	3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade (Motley Fool)
Jun-14-24 09:45AM	Are Dividend Stocks The Best Source Of Passive Income? Here Are Three Alternative Options To Consider (Benzinga)
07:15AM	Is It Too Late to Buy Pfizer Stock? (Motley Fool)
06:37AM	3 Stocks to Sell as Ozempic Surges in Popularity (InvestorPlace)
03:00AM	ELREXFIO Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma (Business Wire)
Jun-13-24 04:04PM	Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test (Investor's Business Daily)
01:07PM	Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open for a Rival (Barrons.com)
01:03PM	Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open (Barrons.com)
11:50AM	Redditors Are Buying These 8 Dividend Stocks For Early Retirement (Benzinga)
08:40AM	Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal (Zacks)
07:00AM	Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision (BioPharma Dive)
06:33AM	Flagship Pioneering and ProFound link for obesity therapies (Pharmaceutical Technology)
05:21AM	3 Ultra-High-Yield Dividend Stocks Billionaires Are Sinking Their Teeth Into (Motley Fool)
04:12AM	Pfizers Phase III DMD gene therapy trial misses primary endpoint (Clinical Trials Arena)
Jun-12-24 05:45PM	Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors (Zacks)
05:02PM	Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne muscular dystrophy (FierceBiotech.com)
04:30PM	Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy (Business Wire)
01:46PM	Pfizer gene therapy for Duchenne fails to meet goals of key trial (BioPharma Dive)
10:00AM	Pfizer: An Oversold Pharma Stock in Recovery (GuruFocus.com)
08:35AM	Flagship taps startup to hunt for obesity drugs that might interest Pfizer (BioPharma Dive)
08:28AM	Pfizer, Flagship name first target for multi-billion dollar collaboration: obesity (FierceBiotech.com)
Jun-11-24 02:49PM	7 Recession-Proof Stocks to Buy Now for Peace of Mind (InvestorPlace)
12:58PM	Why AstraZeneca plc (NASDAQ:AZN) is Investors' One of Favorite International Dividend Stock? (Insider Monkey)
10:00AM	3 Penny Stocks to Buy if You Want to Spend Less and Earn More (InvestorPlace)
08:37AM	30 Wealthiest People in Germany (Insider Monkey)
08:20AM	Is this the Time to Initiate a Pfizer (PFE) Position? (Insider Monkey)
08:02AM	FuelCell Energy, Inc. (NASDAQ:FCEL) Q2 2024 Earnings Call Transcript (Insider Monkey)
06:00AM	3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants (InvestorPlace)
05:21AM	Billionaires Are Buying These 2 Ultra-High-Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio? (Motley Fool)
05:10AM	Bull Market and Beyond: 3 Stocks Just Waiting to Soar (Motley Fool)
Jun-10-24 09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-08-24 06:50AM	3 Stocks With Mouthwatering Dividends You Can Buy Right Now (Motley Fool)
Jun-07-24 03:02PM	Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds (Reuters)
10:19AM	Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead (Benzinga)
09:30AM	2 Dividend Stocks Billionaires Are Buying: Should You? (Motley Fool)
08:03AM	ABM Industries Incorporated (NYSE:ABM) Q2 2024 Earnings Call Transcript (Insider Monkey)
Jun-06-24 04:37PM	Novavax's stock surges almost 300% in the past month (Yahoo Finance)
09:28AM	Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock? (InvestorPlace)
Jun-05-24 06:21PM	FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines (Associated Press Finance)
04:05PM	Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 (GlobeNewswire)
09:49AM	Here's Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY) (Insider Monkey)
09:30AM	2 High-Yield Dividend Stocks to Buy Right Now (Motley Fool)
07:45AM	Why Things Could Get Worse for Pfizer Stock Before They Get Better (Motley Fool)
06:40AM	7 Dividend Stocks to Invest In for a Lifetime of Income (InvestorPlace)
Jun-04-24 01:59PM	Final Trades: Pfizer, Alphabet, Ventas and ASML Holding (CNBC TV)
01:45PM	Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon (Benzinga)
10:43AM	3 Dividend Stocks You May Want To Double Down On (Benzinga)
07:23AM	Pfizer and Abu Dhabi partners to boost sickle cell disease research (Pharmaceutical Business Review)
07:15AM	GSK shares fall 9% in wake of Zantac court ruling (Pharmaceutical Technology)
06:37AM	The Income Investor's Dream Team: 7 Sturdy Dividend Stocks Yielding 6% (InvestorPlace)
06:00AM	7 High-Yield Dividend Stocks That Work While You Sleep (InvestorPlace)
05:29AM	1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer (Motley Fool)
Jun-03-24 04:20PM	Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
03:41PM	FDA considers updating COVID boosters, Novavax stock reacts (Yahoo Finance Video)
12:54PM	Pfizer CEO: Cancer drugs will be our next big contribution to the world (CNBC TV)
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Feb 23 '24	Option Exercise	27.34	127,674	3,490,607	439,748	Feb 27 01:46 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23 '24	Option Exercise	27.34	95,755	2,617,942	230,920	Feb 27 01:46 PM
SUSMAN SALLY	Executive Vice President	Feb 23 '24	Option Exercise	27.34	63,837	1,745,304	218,148	Feb 27 01:46 PM
JOHNSON RADY A	Executive Vice President	Feb 23 '24	Option Exercise	27.34	29,436	804,780	123,073	Feb 27 01:46 PM
McDermott Michael	Executive Vice President	Feb 23 '24	Option Exercise	27.34	12,412	339,344	95,408	Feb 27 01:47 PM
SAHNI PAYAL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	11,527	315,148	34,604	Feb 27 01:46 PM
BOSHOFF CHRISTOFFEL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	9,752	266,620	148,703	Feb 27 01:44 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23 '24	Option Exercise	27.34	9,752	266,620	19,228	Feb 27 01:46 PM
Gottlieb Scott	Director	Dec 15 '23	Buy	26.47	3,000	79,401	9,000	Dec 19 09:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc.

Upgrade your FINVIZ experience